Form 4: Annexon Director Acquires Stock Options
Statement of Changes in Beneficial Ownership
Annexon, Inc. director Muneer A. Satter acquired 65,000 stock options with an exercise price of $4.70, vesting in June 2026.
Summary
- Muneer A. Satter, a Director at Annexon, Inc., acquired 65,000 stock options on June 11, 2026.
- The options have an exercise price of $4.70 per share.
- These options are for Annexon, Inc. common stock.
- The options are set to expire on June 11, 2036.
- The underlying shares subject to the option vest 100% on the earlier of the first anniversary of June 11, 2026, or the next Annual Meeting following June 11, 2026, contingent on Satter's continuous service as a director.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard grant of options to a director, indicating continued engagement and potential future upside if the company performs well.
Positives
- Director acquisition of stock options signals confidence in the company's future prospects.
- The acquisition is structured with a vesting schedule tied to continued service, aligning management incentives with long-term company performance.
Risks
- The vesting of options is contingent on the reporting person's continuous service as a director, implying a risk of forfeiture if service is terminated before the vesting date.
- The exercise price of $4.70 means the options will only be profitable if the stock price rises above this level.
Future Outlook
The vesting of the stock options is tied to the first anniversary of June 11, 2026, or the next Annual Meeting following June 11, 2026, provided the reporting person remains in continuous service as a director.
Industry Context
StockSavvy.ai notes that director grants of stock options are a common practice in the biotechnology and pharmaceutical sectors, often used as a long-term incentive to retain key personnel and align their interests with shareholder value.
Stakeholder Impact
- Shareholders: The grant of options to a director can be viewed positively as it aligns management incentives with long-term stock performance, potentially leading to increased shareholder value if the stock price appreciates.
- Employees: While not directly impacting employees, such grants can be part of a broader compensation strategy that aims to attract and retain talent.
Next Steps
- Reporting person to remain in continuous service as a director until the vesting date.
- Vesting of 100% of the option shares on the earlier of the first anniversary of June 11, 2026, or the next Annual Meeting following June 11, 2026.
Key Dates
| Date | Description |
|---|---|
| 06/11/2026 | Earliest transaction date and grant date of stock options. |
| 06/15/2026 | Date of signature on the filing. |
| 06/11/2036 | Expiration date of the stock options. |
Keywords
Annexon Inc, ANNX, Form 4, Stock Options, Director, Beneficial Ownership, Securities, Insider Trading, Vesting Schedule
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.